158 related articles for article (PubMed ID: 16433483)
1. [Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
Caletti MG; Gallo G
Medicina (B Aires); 2005; 65(6):528-32. PubMed ID: 16433483
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic uremic syndrome: defining the need for long-term follow-up.
Small G; Watson AR; Evans JH; Gallagher J
Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
[TBL] [Abstract][Full Text] [Related]
3. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
[TBL] [Abstract][Full Text] [Related]
4. [Hemolytic uremic syndrome. Evaluation of clinical and prognostic factors].
Palomeque Rico A; Pastor Durán X; Molinero Egea C; Roca González A
An Esp Pediatr; 1993 Nov; 39(5):391-4. PubMed ID: 8285450
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of hemolytic uremic syndrome after acute stage].
Ye LY; Yu ZH; Huang ZX; Chen XM; Ren RN; Chen GM; Wang CF; Xia GZ; Huang J; Wang FJ
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):206-9. PubMed ID: 16624060
[TBL] [Abstract][Full Text] [Related]
6. [Hemolytic-uremic syndrome in children: a 19-year retrospective study].
Imoberdorf G; Bianchetti MG; Rossi E; Gugler E; Oetliker OH
Schweiz Med Wochenschr; 1993 Jul; 123(29):1439-44. PubMed ID: 8367702
[TBL] [Abstract][Full Text] [Related]
7. [Different effect of angiotensin convertase inhibitors and AT1 receptor blockers on renal function in patients with chronic renal failure: report of two cases].
Litwin M; Prokurat S
Pol Merkur Lekarski; 2000 Apr; 8(46):295-6. PubMed ID: 10897659
[TBL] [Abstract][Full Text] [Related]
8. [Hemolytic uremic syndrome: long term renal injury].
Lumbreras Fernández J; Cruz Rojo J; Iñigo Martín G; Muley Alonso R; Vara Martín J
An Pediatr (Barc); 2010 May; 72(5):309-16. PubMed ID: 20347408
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic-uremic syndrome with renal thrombotic microangiopathy].
Kanfer A
Rev Prat; 1994 May; 44(9):1205-10. PubMed ID: 7939344
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome.
Mehrazma M; Hooman N; Otukesh H
Iran J Kidney Dis; 2011 Nov; 5(6):380-5. PubMed ID: 22057069
[TBL] [Abstract][Full Text] [Related]
11. Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome.
Dieguez S; Ayuso S; Brindo M; Osinde E; Cánepa C
Nephron Clin Pract; 2004; 97(3):c118-22. PubMed ID: 15292689
[TBL] [Abstract][Full Text] [Related]
12. [Hemolytic and uremic syndrome in the adult].
Vigneau C; Rondeau E
Nephrologie; 2002; 23(4):165-71. PubMed ID: 12125322
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
[TBL] [Abstract][Full Text] [Related]
14. Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome.
Edefonti A; Bettinelli A; Mondonico P; Claris Appiani A; Picca M; Cossu MM; Tentori F; Giani M; Rossi E
Clin Nephrol; 1985 Apr; 23(4):207-11. PubMed ID: 4006329
[TBL] [Abstract][Full Text] [Related]
15. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.
Bláhová K; Janda J; Kreisinger J; Matejková E; Sedivá A
Pediatr Nephrol; 2002 Jun; 17(6):400-3. PubMed ID: 12107802
[TBL] [Abstract][Full Text] [Related]
17. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.
Garg AX; Suri RS; Barrowman N; Rehman F; Matsell D; Rosas-Arellano MP; Salvadori M; Haynes RB; Clark WF
JAMA; 2003 Sep; 290(10):1360-70. PubMed ID: 12966129
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].
Zambrano O P; Delucchi B A; Cavagnaro S F; Hevia J P; Rosati M MP; Lagos R E; Nazal Ch V; González C C; Barrera B P; Alvarez L E; Pinto S V; Salas del C P; Cano Sch F; Contreras M A; Galanti de la P M; Gana A JC; Zamorano C J; Espinoza B A; Dreves R P; Pereira M J; Bidegain S A; Pasten P E; Yáñez P L; Cerda F V; Rodríguez S E; Aglony I M; Gutiérrez I E; Salas P F; Figueroa Y S; Valenzuela A M; Grandy H J; Guerra A B; Lapadula A M; Reutter de la M P; Gallardo T V; Maldonado S D; Azócar P M; Cavada Ch G
Rev Med Chil; 2008 Oct; 136(10):1240-6. PubMed ID: 19194619
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis--angiotensin II immunostaining and treatment outcome.
Mizuiri S; Kawamura T; Miyagi M; Arai K; Sakai K; Aikawa A; Ohara T; Shibuya K; Ishikawa Y; Kawamura S; Hasegawa A
Clin Transplant; 2005; 19 Suppl 14():12-9. PubMed ID: 15955164
[TBL] [Abstract][Full Text] [Related]
20. Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.
Caletti MG; Gallo G; Gianantonio CA
Pediatr Nephrol; 1996 Dec; 10(6):687-92. PubMed ID: 8971879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
